SkinBioTherapeutics Names Interim CFO

MT Newswires · 3d ago
02:50 AM EDT, 08/24/2026 (MT Newswires) -- SkinBioTherapeutics (SBTX.L) said Monday it appointed Anita Slater as interim chief financial officer. With immediate effect, Slater will assume the role for an initial six-month term, the skin health-focused life science company noted.